logo

Neovasc Inc. (NVCN)



Trade NVCN now with
  Date
  Headline
7/26/2022 9:20:20 AM Neovasc :FDA Approves COSIRA II Sub-studies And Single Arm Registry To Allow Inclusion Of Addl Patient Populations
3/20/2015 10:52:17 AM Leerink Starts Neovasc Inc. (NVCN) At Outperform With $25 Price Target